News
An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.
Trump's order is designed to reduce health care costs for older adults and people with disabilities, but the path to ...
A small increase in the autism rate suggests diagnosis and access to care are improving, researchers say — and don't herald a ...
Researchers will soon test whether livers from a gene-edited pig could treat people with sudden liver failure — by ...
Join STAT reporters for a virtual recap of ASCO 2025 — highlighting the latest breakthroughs, industry news, and key moments ...
Critiques of the vaccine injury reporting system have long been part of Kennedy’s efforts to questions the safety of ...
J&J also raised its full-year revenue guidance to include sales of the psychiatric drug Caplyta, which the company got from ...
I don’t think an algorithm can re-create the specifically human experiences” of penning a physician note that will be ...
Academic groups announced an effort to develop a “simple and easily explained model” of funding indirect research costs ...
The head of Mass General Brigham said officials at the Harvard-affiliated health system believe the Trump administration's funding freeze shouldn’t apply to MGB.
Pharmalittle: We’re reading about Trump team moving on pharma tariffs, PBMs under pressure, and more
Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to imposing tariffs ...
Sarah Fortune, Harvard tuberculosis expert, says a Trump administration order could lead to scientist layoffs and the deaths of research monkeys.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results